Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives. - Wikidata - wikimedia - TriplyDB

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.

http://www.wikidata.org/entity/Q35810790

about

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.A 12-mer repetitive antigenic epitope from Trypanosoma cruzi is a potential marker of therapeutic efficacy in chronic Chagas' disease.Bug Smash, Bug Splash: A Case Report of an Unusual Transmission of American Trypanosomiasis with a Brief Review of the Literature.Antiparasitic Treatment Induces an Improved CD8+ T Cell Response in Chronic Chagasic Patients.A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole

P2860

Q36720271-5C5FDA81-97DA-467E-BD36-6FAF50C7052C Q37717875-7DF5B702-6232-4AC6-A3F8-DDFC1AD2B755 Q39002789-9E77B4CA-AE2E-4FEA-828D-DDFE9297FE72 Q39061624-EE69553D-1303-4151-A02C-357D0B5132F1 Q40309242-BA02F73A-8EE0-4F9E-905F-1BF940051C86 Q50099507-C0BB9BD7-A1F1-43F7-B33B-99B390411464 Q58573679-B8335EC0-C24A-4A9A-8AE5-53CC783D30CF

P2860

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.

http://www.wikidata.org/entity/Q35810790

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Biomarkers of therapeutic resp ...... e art and future perspectives.

@ast

Biomarkers of therapeutic resp ...... e art and future perspectives.

@en

type

label

Biomarkers of therapeutic resp ...... e art and future perspectives.

@ast

Biomarkers of therapeutic resp ...... e art and future perspectives.

@en

prefLabel

Biomarkers of therapeutic resp ...... e art and future perspectives.

@ast

Biomarkers of therapeutic resp ...... e art and future perspectives.

@en

P1433

Q35810790-3805E3F4-4450-4FAF-81D5-690C15570C65

P1476

Q35810790-5CC557D0-3BEB-44DB-8CF6-87C81119B0E6

P2093

Q35810790-2130A7D6-F524-4510-B4AB-59C28DF293DC

P275

Q35810790-8B69CA45-DCA7-4937-A168-6FF68C108431

P2860

Q35810790-01F7DF2C-E4F8-4C99-A2C8-1220263DF778

Q35810790-04E0D013-E6C7-4FBD-811D-3108B1071536

Q35810790-06702EA1-E0A8-4111-A1DD-0371CDD8D792

Q35810790-06A29F22-C599-4C1C-AE77-C85D6897965F

Q35810790-06B24F92-EB5C-41F6-8BC5-D8AFA227B185

Q35810790-088F8502-0DAA-401D-9EE6-5B454A41366B

Q35810790-08B2F0E8-4B33-448C-9FE2-79238536E29F

Q35810790-094373CB-243F-4F26-99AF-9600D40D04FA

Q35810790-0B1AA81A-00F0-4952-B544-8FDCC17EB10E

Q35810790-0E643183-685F-4C43-BB27-B2244093AA5D

P304

Q35810790-143AFF6D-A0ED-41B4-BE6B-0B4EBEB42847

P31

Q35810790-454B3AE9-AD3D-4FC9-86DE-83FA4D6F926C

Q35810790-F14F495E-37A2-4ADE-BDD1-F58CFE3E9C38

P356

Q35810790-436BF34D-40F8-49F9-B689-36C660F8F358

P433

Q35810790-15396571-DDB9-4C92-B318-CE2E0AD355DC

P478

Q35810790-E6D62E65-E67E-4C48-AEB1-89732DA0DC60

P50

Q35810790-6ACAA796-7FAE-4375-9C71-A31A8883B5EE

Q35810790-7272E94D-5BE5-431F-8625-B139D9D764BC

Q35810790-99CA59CD-F638-4428-89A9-BDC2EDC26CCE

Q35810790-A279F523-6DD7-4CC8-9E94-995E6F379073

Q35810790-E627C353-1F99-4790-9EDE-4E93A27B2BA7

P5008

Q35810790-EA051AC7-4462-40F9-B67B-B76184FF13A0

P577

Q35810790-1ADDEC10-A2A1-4EFA-B893-A7F38D519ADB

Q35810790-6045EE95-0150-496C-B3BE-B795DFF48926

P5875

Q35810790-BED37E8E-129B-42D8-9750-FA142132857B

P698

Q35810790-DCFC21BB-C318-4E29-94B8-EEE5D4E389F9

P921

Q35810790-534E8A6D-2E9C-4DB1-8D98-D68DE44E1E78

Q35810790-693E4FAD-46C4-4085-935B-D5031D4F83CA

Q35810790-CF12F23D-03E6-4845-A8A6-3B2EA2AF93ED

Q35810790-E2F89B71-7999-4CAA-A1ED-65B41757533A

P932

Q35810790-91009272-7D43-4D03-A69F-C7D6F688F9CB

P356

0074-02760140435

P1433

Memórias do Instituto Oswaldo Cruz

P1476

Biomarkers of therapeutic resp ...... e art and future perspectives.

@en

P2093

Juan Bustamante

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study

Interleukin-10 and the interleukin-10 receptor

VNI cures acute and chronic experimental Chagas disease

What are biomarkers?

Development of an aptamer-based concentration method for the detection of Trypanosoma cruzi in blood

CD40-CD40 ligand

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Macrophage inflammatory protein-1

A critical review on Chagas disease chemotherapy

Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant

P304

422-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/0074-02760140435

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

María Jesús Pinazo

Joaquim Gascón

P5008

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275722363

http://www.w3.org/2001/XMLSchema#string

P698

25946151

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

P932

4489480

http://www.w3.org/2001/XMLSchema#string